T
he Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure and its shortened version (QuickDASH) are 2 region-specific measures of disability and symptoms in people with musculoskeletal disorders of the upper limb. 4, 18 Both have been widely used and are available in different language versions. 6, 34 A prerequisite for meaningful use of such patient-reported outcome measures is the quality of their clinimetric properties. Strengths and weaknesses of the DASH and Quick-DASH have been well investigated by both classical test theory 1, 23 and Rasch analysis, 12, 13 but many different approaches have been used to calculate the responsiveness of these measures, in particular the minimal clinically important difference (MCID), also known as the minimal important change, which focuses on within-person change over time. 3, 21 The MCID represents the smallest improvement in score to reflect a change that is clinically meaningful for the patient. 17 The MCID threshold is very important in daily practice, where clinicians routinely compare, at the individual level, the current and previous values of outcome measures of interest. 39 Distribution-and anchor-based methods are the 2 general approaches that have been used to interpret score changes. However, each method has its shortcomings. The major disadvantage of distribution-based approaches is that they do not provide a good indication of the importance of the observed change and thus cannot give the MCID. 10 Their main role lies in identifying the minimum detectable change (MDC), that is, the smallest change in score that can be detected beyond random error. 41 On the T T STUDY DESIGN: Prospective, single-group observational design.
T T OBJECTIVES:
To determine the minimal clinically important difference (MCID) for the Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure and its shortened version (QuickDASH) in patients with upper-limb musculoskeletal disorders, using a triangulation of distribution-and anchor-based approaches.
T T BACKGROUND:
Meaningful threshold change values of outcome tools are crucial for the clinical decision-making process.
T T METHODS:
The DASH and QuickDASH were administered to 255 patients (mean  SD age, 49  15 years; 156 women) before and after a physical therapy program. The external anchor administered after the program was a 7-point global rating of change scale.
T T RESULTS:
The test-retest reliability of the DASH and QuickDASH was high (intraclass correlation coefficient model 2,1 = 0.93 and 0.91, respectively; n = 30). The minimum detectable change at the 90% confidence level was 10.81 points for the DASH and 12.85 points for the QuickDASH. After triangulation of these results with those of the mean-change approach and receiver-operatingcharacteristic-curve analysis, the following MCID values were selected: 10.83 points for the DASH (sensitivity, 82%; specificity, 74%) and 15.91 points for the QuickDASH (sensitivity, 79%; specificity, 75%). After treatment, the MCID threshold was reached/surpassed by 61% of subjects using the DASH and 57% using the QuickDASH.
T T CONCLUSION:
The MCID values from this study for the DASH (10.83 other hand, the accuracy of results of anchor-based methods, which can provide the MCID, depends among other things on the choice of the anchor, 2 the definition of "minimal importance" on the anchor, and baseline values, type of population, and contextual characteristics.
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Because it is common for these different methods to yield different threshold values, recent papers recommend that the MCID be based primarily on anchorbased procedures, 32 be higher than MDC values (the boundary of variability typically found in stable patients), 32, 41 and not be based on 1 study or 1 method only. 40 However, the studies calculating MCID through anchor-based approaches are limited for both the DASH 2, 3, 9, 24, 25, 35, 36 and QuickDASH. 24, 27, 30, 36 In addition, it appears that the best choice to determine MCID is to select a small range of threshold estimates after comparing and interpreting the information conveyed by multiple reference standards, calculated on the same sample. 32, 39, 40 To date, such an approach has only recently been applied for the DASH in a study 3 dealing with soft tissue shoulder disorders. Therefore, further investigation of these outcome measures is needed to establish the stability of prior reports and to investigate MCID values in other cohorts, so as to provide useful insights about the magnitude of change in score that could be considered a clinically meaningful improvement.
The main aim of this study was to use both distribution-and anchor-based methods to triangulate on MCID values for the DASH and QuickDASH in a large sample of patients with upper-limb musculoskeletal disorders who were undergoing physical therapy, to enhance confidence in interpreting their change scores for clinical decision making.
METHODS

Subjects
T
his prospective observational study was carried out at the Salvatore Maugeri Foundation Scientific Institute of Veruno, Italy in 266 consecutive adult inpatients and outpatients referred for an intensive upperlimb physical therapy program. To be included, participants had to be adults over 18 years of age and to be suffering from upper-limb musculoskeletal disorders. Those who had severe cognitive or communication impairments, pain in the upper limb arising from other regions (eg, the neck), a diagnosis of central nervous system or psychiatric disorders, and a history of tumor malignancy were excluded from the study. Prior to taking part in the study, all participants signed an informed consent form approved by the Ethics Committee of the hospital. After excluding data from incomplete surveys (n = 4) and patients lost to follow-up (n = 7), 255 patients remained as the final study population. 
Assessment
Disabilities of the Arm, Shoulder and
Hand The DASH 18 is a region-specific measure of disability and symptoms in people with any or multiple musculoskeletal disorders of the upper limb. The items inquire about (1) the degree of difficulty during the preceding week in performing various physical activities because of problems in a shoulder, arm, or hand (21 items); (2) the severity of each of the symptoms of pain, activity-related pain, tingling, weakness, and stiffness (5 items); and (3) the problem's effect on social activities, work, and sleep, and its psychological impact (4 items). There are 5 response options for each item, from 1 (no difficulty to perform, no symptom, or no impact) to 5 (unable to do, very severe symptom, or high impact). The responses to the 30 items are summed to form a raw score that is then converted to a 0-to-100 scale with the following formula: [(sum of score/n) -1] × 25, where n is the number of completed responses. A higher score reflects greater disability. If less than 10% of the items are left blank by the respondent, then the mean value of the responses to the completed items is substituted for each missing item. The full-length Italian version of the DASH, as published on the DASH website (http://www.dash.iwh.on.ca), was used in this study, excluding the optional modules for work and sports/performing arts. Shortened Version of the DASH The QuickDASH 4 is a shortened version of the DASH questionnaire that uses 11 items to measure the degree of difficulty in performing various physical activities due to a shoulder, arm, or hand problem (6 items); the severity of pain and tingling (2 items); and the problem's ef- fect on social activities, work, and sleep (3 items). It uses the same 5 response options of the DASH. In this study, the QuickDASH item responses were extracted from the subjects' responses to the full-length questionnaire. If at least 10 of the 11 items were completed, the responses to the items were summed to form a raw score, then converted to a 0-to-100 scale with the same formula used to calculate the DASH score, with higher scores reflecting greater disability. The 2 optional scales of the QuickDASH (work and sport/music) were not part of this study.
Global Rating of Change Scale
The global rating of change scale (GRCS) is a rating scale designed to quantify a patient's improvement/deterioration over time, usually to determine the effect of an intervention or to chart the clinical course of a condition. At the time of the final assessment (after the rehabilitation treatment), patients were asked to independently rate the overall change in their upper-limb condition from when they began treatment, using a 7-point scale ranging from -3 (a great deal worse) to +3 (a great deal better), with 0 indicating "unchanged." 21 The self-assessment value was used as an external anchor, with patients who rated their improvement from 0 to +1 (a little better) being considered as not improved or minimally improved and those who rated their improvement as +2 (somewhat better) or higher being considered as moderately to largely improved. 41 
Procedure
All patients completed the full-length DASH questionnaire (written format) at the first and last sessions of a tailored, comprehensive physical therapy program that included, when indicated, passive or active mobilization, stretching, strength training, and functional exercises. Sessions were planned twice or 3 times weekly. At the end of the intensive physical therapy program, which lasted 2 to 5 weeks, patients also completed the GRCS. Three physical therapists (S.V., F.S., E.B.) distributed all questionnaires and collected answer sheets. Test-retest reliability was analyzed in a subset of 30 consecutive patients (mean  SD age, 50  13 years; 10 women) who were assessed twice, 1 to 3 days prior to treatment and at the start of the treatment.
Statistical Analysis
Descriptive Statistics, Validity, and Reliability Descriptive statistics were calculated for the DASH, QuickDASH, and GRCS. All statistical analyses were performed using Stata/IC Version 10.1 (StataCorp LP, College Station, TX).
Convergent validity was assessed by calculating the Pearson correlation coefficient (r) of the total scores of the DASH and QuickDASH at the first evaluation and follow-up and the change in score from first evaluation to follow-up. In addition, because the GRCS was the reference standard (ie, the external criterion against which we judged if a real improvement in patients had occurred), it assessed the same construct measured by the tools under longitudinal investigation. 42 Thus, the correlation between the GRCS and the change (after versus before rehabilitation) in the 2 questionnaires was calculated. For all these correlations, an at least fair association (r>0.30) between measures was expected. 32 Test-retest reliability was calculated for both scales using an intraclass correlation coefficient (ICC 2,1 ). We determined the sample size for test-retest reliability, expecting to obtain ICC values of at least 0.90 with a confidence interval (CI) of 0.20.
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Responsiveness The 2 main methods of evaluating the ability of a measure to detect changes are a distribution-based method and an anchor-based method. Distribution-based methods rely on statistical characteristics of the sample and analyze the ability to detect change in general. Anchor-based methods require an external patient-based criterion (anchor) to determine if changes in outcome scores are clinically meaningful. 8 We used both approaches to have a wider range of results from which to draw inferences about the MCID of both scales, aware of the large variation and lack of convergence that these different methods can have. 40 For the distribution-based methods, we calculated the standard error of measurement (SEM), which links the reliability of a measurement tool to the standard deviation of the population. 10 The SEM was calculated from the analysis of variance used to produce the test-retest ICC. 38 Starting from the SEM, we calculated the MDC, which represents the smallest change in score likely to reflect true change, free of measurement error. 37 The calculation is the result of the multiplication of the SEM by the z-value by the square root of 2. The 90% confidence level (MDC 90 ) was established, corresponding to a z-value of 1.65. The meaning of this statistic is that if a patient has a change score equal to or above the MDC 90 threshold, it is possible to state with 90% confidence that this change is real and not due to measurement error.
Regarding anchor-based methods, the mean-change and receiver-operatingcharacteristic (ROC) curve approaches were followed, and GRCS assessment was used as the external reference in evaluating responsiveness. For the mean-change approach, we calculated the mean change score in the different subgroups of patients who respectively reported themselves on the anchor as not improved (GRCS, 0), minimally improved (GRCS, +1), moderately improved (GRCS, +2), or largely improved (GRCS, +3). We used the mean change in those minimally improved for triangulating the MCID values. 40 For the ROC curve approach, we determined the optimal cutoff score and the area under the curve (AUC), considering the subjects improved according to a GRCS of +2 or greater. A ROC curve plots sensitivity (y-axis) against 1 -specificity (x-axis). In this context, sensitivity was calculated as the number of patients correctly identified as improved based on the cutoff value divided by all patients identified as having had a meaningful change (GRCS, +2 or greater), whereas specificity refers to the number of patients who were correctly identified as not improved based on the cutoff value divided by all patients who truly did not have a meaningful change (GRCS, less than +2). The optimal cutoff was chosen as the point that jointly maximized sensitivity and specificity (was associated with the least amount of misclassification). The AUC can be interpreted as the probability of correctly identifying a patient who has improved in randomly selected pairs of patients who have and have not shown an improvement. The greater the AUC, the greater a measure's ability to distinguish patients who have improved from those who have not improved. As a general rule, AUC values between 0.7 and 0.8 are judged as acceptable, and an AUC value greater than 0.8 is considered to have good to excellent discrimination. 44 In accordance with Turner et al, 42 our ROC analysis used the entire cohort, rather than just those subjects with ratings adjacent to the dichotomization point, to increase precision and obtain more logical estimates of the MCID. To obtain CIs for the ROC-derived parameters, we drew 500 bootstrap samples and calculated both the cutoff value and the AUC in each bootstrap replication. The mean of the 500 bootstrap AUC values was taken as the best estimate, with the 95% CI calculated as 1.96 × SD (as an estimate of the standard error) of the bootstrap values. 40 Once the best cutoff value was estimated, we used the sensitivity and specificity at this value in each of the 500 ROCs obtained by bootstrapping to compute mean and 95% CI for these parameters.
The MCID was set at the best triangulation of the results coming from both anchor-based (mean change and the ROC curve) and distribution-based (the MDC 90 threshold) methods, considering that the MCID should be based primarily on anchor-based procedures 32 and be higher than the MDC value. 9, 41 In this regard, the MDC should be interpreted as another piece in the puzzle toward establishing the MCID, by benchmarking it to the boundaries of error. According to Turner et al, 41 "if the two anchor-based methods calculated on the same population yield different MCID values, then the knowledge that one value is below the MDC could aid in the decision to select the other." In addition, the ROC-curve approach was preferred as the first choice, as it successfully addresses most limitations of the mean-change approach. 32, 40, 42 Furthermore, our calculation of the 95% CIs gave a useful indication of the sampling variation. 10 In addition, patients who reached (or surpassed) MCID thresholds were considered positive responders. Then, we calculated how many positive responders showed a final score of 16 points or less, which was lower than both the fifth percentile of our dysfunctional population at baseline (16.42 Splitting data according to the presence of a moderate versus large GRCS improvement (GRCS less than +2 versus GRCS of +2 or greater), the AUC of the DASH was 0.87 (95% CI: 0.84, 0.91), and that of the QuickDASH was 0.86 (95% CI: 0.82, 0.89) (FIGURE 3) . The cutoff scores that best identified meaningful improvement in clinical status (as measured by GRCS values of +2 or greater) were 9.17 (95% CI: 7.50, 10.83) for the In our cohort, the percentage of positive responders, that is, those who reached or surpassed the MCID threshold (after a median number of 10 physical therapy sessions), was 61% using the DASH and 57% using the QuickDASH. Moreover, 128 of the 151 subjects (85%) who had a moderate to large improvement (GRCS of +2 or greater) showed a change after physical therapy equal to or higher than the MCID (10.83 points) on the DASH, whereas 119 (79%) showed a change equal to or higher than the MCID (15.91 points) on the QuickDASH. Among them, 45 subjects for the DASH and 46 for the QuickDASH (coefficient of agreement, 87%) attained a "good" final state (final score of 16 points or less). In addition, among the 43 patients who reported a small improvement (GRCS, +1), 22 (51%) showed a change of 10.83 points or greater on the DASH, and 21 (49%) showed a change of 15.91 points or greater on the QuickDASH. In the remaining GRCS categories (GRCS of 0 or less), no subjects showed a positive change equal to or higher than the respective MCIDs.
DISCUSSION
A ssessing patient progress is an integral part of clinical practice, and meaningful threshold change values of outcome tools are essential for decision making regarding a patient's status and to facilitate the communication of results in a concise and comprehensible fashion. This study used both distribution-and anchor-based approaches to define clinically meaningful MCID values for the DASH and QuickDASH. Triangulation of our results considered that the MCID should be based primarily on anchor-based procedures (and in the first instance on the ROC curve) 32 and be higher than the MDC value. 9,41 These MCID thresholds represent the smallest improvement considered worthwhile by a patient, and thus increase the interpretability of score changes at the individual level observed in the clinical setting.
The high correlation between the DASH questionnaire and its shortened version, and between their changes after a rehabilitation intervention, supports the convergent validity of the 2 measures. In this study, the QuickDASH scores were extracted from the full-length DASH responses, and it is not known if patients' responses to the 11 items would have differed if only the QuickDASH had been administered; however, this method has been shown to be sound in a previous study. 16 In addition, the ability of the participants to estimate the change in their upper-limb disability during the treatment period was confirmed by the [ research report ] good correlation of their GRCS assessment with change in both the DASH and QuickDASH.
The responsiveness indices calculated with distribution-based methods showed values very close to those reported in the literature. For the DASH, our MDC 90 was 10.8 points, compared to values ranging from 6.5 to 14.5 in the literature, 1, 2, 9, 24, 34, 35 whereas the MDC 95 reported on the DASH website and in the DASH manual ranges from 7.9 to 17.2 points. 24, 40 In particular, our value is very close to that reported by DASH developers (MDC 90 = 11 points).
2 Likewise, our MDC 90 for the QuickDASH was 12.85 points, compared to values ranging from 11 to 15.7 points in the literature, 1, 14, 23, 27, 30, 31 whereas the MDC 95 reported on the DASH website ranges from 16 to 20 points. 20 It is important to recognize that (a) the MDC values reflect the specific ICC and standard deviation values in each particular study, and therefore different groups of patients would be expected to generate different values; (b) changes below the MDC threshold could be interpreted at an individual level as random fluctuations in score rather than actual change 39 ; and (c) the lower the reliability coefficient, the greater the SEM and the higher the MDC will be. Overall, these MDCs fall within the range of values reported by the DASH manual 24 and provide supportive information for MCID estimates. Their variability in the literature is mainly due to differences in experimental conditions (eg, observers, scoring procedures, population under study).
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As for anchor-based methods, the first issue related to the appropriateness of cutoff values is the selection of the anchor. We used a 7-point GRCS (3 positives, 3 negatives, and an "unchanged" category) and considered patients with GRCS values of +2 or greater (+2, somewhat better; +3, a great deal better) as significantly improved and the others as not significantly improved. 28, 42 In the literature, there is no agreement on the type of GRCS to use, the threshold at which to dichotomize the GRCS, or which groups to include in the analysis. 42 For example, the choice to include in the "changed" group those who reported only slight improvement (GRCS of +1, a little better) would inevitably lead to a lower cutoff point in the ROC analysis. 9 In addition, different criteria have been used to calculate and select both ROC cutoff values and MCIDs in DASH and QuickDASH studies. 2, 3, 9, 25, 27, 36 Finally, the alternate use of raw scores 25 and 0-to-100 converted scores (rounded or not) represents a further potential source of confusion. Overall, any direct comparison of MCIDs is difficult, due to methodological issues that include type of anchor, calculation procedures, decision rules, and so on. 24, 40 An additional problem is that some of the proposed MCIDs are lower than their respective MDC values. 9, 27 After triangulation of all our results, for the DASH, a change of 10.83 points was defined as the most acceptable MCID for moderate improvement, with good sensitivity (82%), specificity (74%), and classification accuracy (79%). 10 This MCID was inside the 95% CI for our ROC cutoff values, slightly superior to both our MDC 90 (10.8 points) and the MDC 95 (10.7 points) reported by Beaton et al, 3 and in line with the MCID (10 points; 95% CI: 5, 15) calculated in a sample of patients undergoing nonoperative treatment for forearm, wrist, and Various authors have suggested that it would be better to define a range of MCID values rather than a fixed value, 10, 11 and there are reasons to be skeptical about claims of a single MCID value. 24 Overall, due to our methodological procedure, with its main focus on the ROCcurve approach and an MCID value higher than MDC 90 and not MDC 95 , our threshold of 10.83 points could represent the lower boundary for a small range of reasonable MCIDs, in which the upper boundary could be represented by the 15 points proposed by the DASH website, 20 according to Beaton et al, 2 who just considered the AUC in ROC curves for score changes of -1, -5, -7, -10, -15, and -20. Also in this range is the MCID value (12.6 points) calculated by Schmitt and Di Fabio 35 in a sample of 78 patients suffering from a mixture of diagnoses involving the upper extremity. Lehman et al, 25 however, reported a slightly higher cutoff point in their ROC-curve analysis (16.7 points), because they privileged the cutoff value with higher specificity.
Similarly, for the QuickDASH, we identified a change of 15.91 points as the most adequate MCID. This is higher than its MDC 90 (12.85 points) and corresponds to the best ROC cutoff value, with a trade-off between sensitivity (79%) and specificity (75%) very close to that of the DASH MCID and, again, good classification accuracy (78%). This MCID is in line with that calculated by Sorensen et al 36 (14 points; 95% CI: 9, 20) and with the MDC 95 of 15.8 points in the original study by Beaton et al. 4, 24 Moreover, it is higher than the 8-point MCID proposed by Mintken et al 27 for the QuickDASH; however, in that study the MDC 90 was 11.2 points. Again, our threshold of 15.91 points could represent the lower boundary for a range of MCIDs having an upper boundary of 18 to 20 points, the limit suggested by the DASH website. 40 20, 24 Taking into account the variation of MCID thresholds that can be found among populations, approaches, and methods used to calculate them, 3, 40 the choice of the threshold within our range of MCIDs should be clinically driven. Using high thresholds for the DASH and QuickDASH, fewer people would be identified by the instrument as having shown a minimal clinically important change, but more people would be classified as not having shown a clinically important improvement 25 ; this could reduce, for example, the risk of a too-early discharge in the clinical context. For an extensive discussion about these issues, we refer to the latest version of the DASH and QuickDASH user's manual. 24 These MCID thresholds identify patients with a clinically important improvement, not those who have recovered. For this reason, to better understand the effects of treatment in some clinical settings, the construct of a return to "normal" functioning (that again could be linked to different indicators) 3 should also be taken into account, as we have done by calculating how many subjects both experienced an MCID and moved into a healthy functional range. This (conservative) result could be useful, where applicable, for interpreting clinical outcome studies and give us more confidence in clinical decision making. 26 As an example, after a median number of 10 physical therapy sessions, about 60% of our patients-using either of the 2 scales-were positive responders, that is, achieved or surpassed the proposed MCID thresholds. Moreover, among the patients who reported a moderate to large improvement on the GRCS (+2 or greater), 85% showed a change equal to or higher than our MCIDs on the DASH, and 79% on the QuickDASH. Thirty-five to forty percent of subjects belonging to these last positive groups also arrived at a good final state, showing scores of 16 points or less, within a range consistent with that of healthy individuals.
Limitations
A number of potential limitations of this study should be mentioned. Caution is mandatory when interpreting and using these MCID values, particularly considering the intrinsic weaknesses of the GRCS. 7, 22 The GRCS (and the MCID values derived from it) may suffer from subjective retrospective judgments of change (eg, due to recall bias or problematic patient ability to understand the context of improvement). Nonetheless, in our opinion, the problems of recall were unlikely to represent a significant issue, as treatment time was rather short (2-5 weeks) and featured periodic discussions of patients' health status. 22 Moreover, as mentioned in the Introduction, when applying MCIDs in clinical research and practice, one must take into consideration that MCID values are dependent on selected characteristics of the sample (eg, age, disease group, baseline functional status, acuity of the medical condition, and potential for change), as well as on treatment and the time interval between testing. 24, 43 Indeed, it has been recently emphasized that measurement error (and parameters derived from it) is often not constant across different levels of function and related scores, 33 and, because the interval-level scaling properties of the DASH and QuickDASH are not definitively proved, the MCID should be managed cautiously, particu-[ research report ] a useful step toward the ultimate goal of accurately classifying patients' response to treatment using the DASH and Quick-DASH. t
KEY POINTS FINDINGS:
In a large sample of patients (n = 255) with upper-limb musculoskeletal disorders, we calculated the MCID for moderate improvement in the DASH (10.83 points) and QuickDASH (15.91 points) with a combination of distribution-and anchor-based (using the GRCS) approaches. IMPLICATIONS: The combined use of multiple methods for defining the MCID is strongly suggested. At present, the studies that have applied anchor-based approaches seem to converge on a small range of MCID values for both scales. Our results increase confidence in interpreting change in the DASH and QuickDASH for use in clinical decision making. CAUTION: Due to the variation of MCID thresholds among populations and methods, caution is needed when interpreting and using the published MCID values at the individual level, and there is a clear need for improvement and standardization of the MCID methodology.
larly when raw scores are near the range margins. 15 The selection criteria of the present study could have posed a threat to the study's external validity. The sample was a cross-section of adults with upper-limb musculoskeletal disorders of different origin and severity (TABLE 2) , recruited with a consecutive sampling method in a single rehabilitation facility. However, the distribution of baseline scores of the sample was consistent with other large studies on the DASH. 2 In addition, our rules for defining positive responders were tailored to our sample and setting. Different populations, rules, indicators, or cutoffs could lead to different results.
Finally, we cannot exclude that some specific (linguistic, cultural, or technical) characteristics of the Italian version of the DASH and QuickDASH might have influenced results, although these versions were the ones suggested by the DASH website, 20 obtained by means of a thorough forward/backward-translation process, 29 and further checked through a pilot test and expert analysis, without finding any major problem.
CONCLUSION T
his study proposes MCID values for the DASH and QuickDASH based on a comprehensive triangulation of distribution-and anchor-based approaches. Our results seem sound from both a psychometric and clinical point of view, and are in line with the previous literature. Our MCIDs for the DASH (10.83 points) and QuickDASH (15.91 points) could represent the lower boundary of a small range of MCIDs that could be proposed for different populations and contextual characteristics, 1, 3, 20 where the upper boundary would be represented by 15 points for the DASH and 20 points for the QuickDASH, as proposed by the DASH website. 20 On the other hand, we agree that there is a clear need for improvement and standardization of the MCID methodology. 40 With this premise, our results are likely to be
